One of the first frontiers of CRISPR gene editing is targeting diseases related to the eye. A diverse Morgridge and UW–Madison team is working to make future applications precise, safe and reproducible.
The post A research partnership brings gene editing promise to eye disease appeared first on Morgridge Institute for Research.
Read the full article at: https://morgridge.org/story/a-research-partnership-brings-gene-editing-promise-to-eye-disease/